Immunology and Microbiology
Transcription Factors
100%
Proteasome
100%
Fallopian Tube
100%
Upregulation
50%
Normal Human
50%
Gene Mutation
50%
Epithelial Mesenchymal Transition
50%
Chemokine
50%
Downregulation
50%
Protein Expression
50%
Chromatin Immunoprecipitation
50%
Protein Family
50%
Binding Affinity
50%
RNA Sequence
50%
Immune Evasion
50%
DNA Binding
50%
Protein Expression Level
50%
Cadherin
50%
Transposase
50%
Transcription Factor GATA 6
50%
Biochemistry, Genetics and Molecular Biology
Carcinogenesis
100%
Epigenetics
100%
Transcription Factors
66%
MEK Inhibitor
66%
Proteasome
66%
Upregulation
33%
Protein Expression
33%
Binding Affinity
33%
Chemokine
33%
Mesenchymal-Epithelial Transition
33%
Gene Mutation
33%
Normal Human
33%
Downregulation
33%
Protein Family
33%
Chromatin Immunoprecipitation
33%
DNA Binding
33%
RNA Sequence
33%
Protein Expression Level
33%
ATAC-Seq
33%
GATA6
33%
Immune Evasion
33%
Cadherin
33%
Genomics
33%
Tamsulosin
33%
Keyphrases
Epigenetic Modification
100%
Integrative Analysis
100%
High-grade Serous Ovarian Cancer (HGSOC)
100%
MEK Inhibitor (MEKi)
18%
Tumorigenesis
18%
Fallopian Tube
18%
Serous Tubal Intraepithelial Carcinoma
18%
Fallopian Tube Secretory Epithelial Cells
18%
Effective Treatment
9%
Cadherin
9%
Treatment Options
9%
Transcription Factor
9%
Protein Expression
9%
Dysregulation
9%
Copy number Variation
9%
Epithelial-mesenchymal Transition
9%
Normal Human
9%
DNA Binding
9%
Genomic Regions
9%
Clinical Efficacy
9%
Gene mutation
9%
Chromatin Immunoprecipitation (ChIP)
9%
RNA Sequencing (RNA-seq)
9%
Family Protein
9%
Expression Change
9%
Chemotherapy Resistance
9%
Inhibitor Treatment
9%
Chemokine Genes
9%
Dysregulated
9%
Proteasome Inhibition
9%
Protein Expression Level
9%
Transcription Factor Binding Sites
9%
Model Cell
9%
Sequence Method
9%
Oncogenic Signaling
9%
GATA6
9%
Alteration Factor
9%
Assay for Transposase-Accessible Chromatin
9%
AP-1 Complex
9%
Complex Families
9%
Inhibitor Therapy
9%
Disabled-2 (Dab2)
9%
Gynecologic Malignancies
9%
Sensory Analysis
9%
GATA Family
9%
Cluster Region
9%
Early Tumorigenesis
9%
Motif Analysis
9%
Oncogenic Alterations
9%
Immune Evasion
9%
FRA16D
9%
Gene Copy number
9%
FOSL2
9%
Medicine and Dentistry
Krukenberg Tumor
100%
Carcinogenesis
27%
Epithelial Cell
18%
Protein Expression
18%
Transcription Factors
18%
Carcinoma in Situ
18%
Fallopian Tube
18%
Proteasome
18%
MEK Inhibitor
18%
Binding Affinity
9%
Cancer
9%
Gene Mutation
9%
Mesenchymal-Epithelial Transition
9%
Chemokine
9%
Downregulation
9%
Upregulation
9%
RNA Sequence
9%
Chromatin Immunoprecipitation
9%
Protein Family
9%
Tamsulosin
9%
Transposase
9%
Transcription Factor GATA 6
9%
Immune Evasion
9%
DNA Binding
9%
Cadherin
9%
Chemotherapy
9%
Pharmacology, Toxicology and Pharmaceutical Science
Ovary Carcinoma
100%
Carcinogenesis
27%
Transcription Factors
18%
Mitogen Activated Protein Kinase Kinase Inhibitor
18%
Proteasome
18%
Carcinoma in Situ
18%
Chemotherapy
9%
Cadherin
9%
Chemokine
9%
Normal Human
9%
RNA-Sequencing
9%
Chromatin Immunoprecipitation
9%
Tamsulosin
9%
Transcription Factor GATA 6
9%
Transposase
9%